LSDs:A Pilot NBS and Examination of the Associated Ethical Legal & Social Issues

Medicine & Life Sciences

1. Neonatal Screening 100%
2. Late Onset Disorders 41%
3. Lysergic Acid Diethylamide 40%
4. Glycogen Storage Disease Type II 22%
5. Lysosomal Storage Diseases 21%
6. Translational Medical Research 17%
7. Natural History 15%
8. Newborn Infant 11%
9. Psychology 10%
10. Mass Screening 9%
11. Phenotype 9%
12. Birth Rate 8%
13. Urban Hospitals 8%
14. Clinical Decision-Making 8%
15. Ethics 7%
16. Age of Onset 7%
17. Health Care Costs 6%
18. Longevity 6%
19. Therapeutics 6%
20. Economics 5%
21. Parents 5%
22. Public Health 5%
23. Interviews 5%